Related Experiment Video
Updated: May 16, 2026
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Minocycline reduces reactive gliosis in the rat model of hydrocephalus
Hao Xu1, Guowei Tan, Shaolin Zhang
1Department of Neurosurgery, First Affiliate Hospital of Xiamen University, Xiamen, Fujian Province 361003, China.
Background:
Reactive gliosis had been implicated in injury and recovery patterns associated with hydrocephalus. Our aim is to determine the efficacy of minocycline, an antibiotic known for its anti-inflammatory properties, to reduce reactive gliosis and inhibit the development of hydrocephalus.
Results:
The ventricular dilatation were evaluated by MRI at 1-week post drugs treated, while GFAP and Iba-1were detected by RT-PCR, Immunohistochemistry and Western blot. The expression of GFAP and Iba-1 was significantly higher in hydrocephalic group compared with saline control group (p < 0.05). Minocycline treatment of hydrocephalic animals reduced the expression of GFAP and Iba-1 significantly (p < 0.05). Likewise, the severity of ventricular dilatation is lower in minocycline treated hydrocephalic animals compared with the no minocycline group (p < 0.05).
Conclusion:
Minocycline treatment is effective in reducing the gliosis and delaying the development of hydrocephalus with prospective to be the auxiliary therapeutic method of hydrocephalus.
Insights
Minocycline effectively reduces reactive gliosis and delays hydrocephalus development in animal models. This anti-inflammatory antibiotic shows promise as an adjunctive therapy for hydrocephalus.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Reactive gliosis is linked to hydrocephalus injury and recovery.
- Hydrocephalus is a condition characterized by the buildup of fluid in the brain.
Purpose of the Study:
- To evaluate minocycline's efficacy in reducing reactive gliosis.
- To determine if minocycline can inhibit hydrocephalus development.
Main Methods:
- Animal models of hydrocephalus were treated with minocycline.
- Magnetic Resonance Imaging (MRI) assessed ventricular dilatation.
- Gene and protein expression of GFAP and Iba-1 were analyzed using RT-PCR, Immunohistochemistry, and Western blot.
Main Results:
- Hydrocephalic animals showed significantly higher GFAP and Iba-1 expression compared to controls.
- Minocycline treatment significantly reduced GFAP and Iba-1 expression in hydrocephalic animals.
- Minocycline-treated animals exhibited reduced ventricular dilatation compared to untreated hydrocephalic animals.
Conclusions:
- Minocycline treatment effectively mitigates gliosis.
- Minocycline demonstrates potential in delaying hydrocephalus progression.
- Minocycline may serve as a supportive therapeutic agent for hydrocephalus treatment.
